DepoProvera

Exploring Potential Mass Tort Litigation: Depo-Provera Cases and Rulemaking Committee’s Role in Legal Funding Decisions

by

Depo-Provera, a long-used injectable contraceptive, is stepping into the legal spotlight as concerns about its potential health risks might bring a wave of litigation, identifying it as a possible new mass tort scenario. Legal experts are debating the implications, considering previous lawsuits that claimed insufficient warning about bone density loss associated with the drug’s prolonged use. With these discussions underway, a committee on judicial proceedings may soon evaluate how litigation funding can influence such lawsuits. The issue of third-party financing in the legal system is contentious, raising questions about the impact on case outcomes and … Read more

Groundbreaking Study Links Depo-Provera to Increased Risk of Brain Tumors, Triggering Wave of Lawsuits Against Pfizer

by

New York — A groundbreaking study published in the British Medical Journal in March has linked the long-term use of Depo-Provera, a popular contraceptive shot, to a significantly increased risk of developing meningioma, a type of brain tumor. This revelation has led to a surge in product liability lawsuits as individuals seek compensation from Pfizer, the pharmaceutical giant behind the drug. Depo-Provera is a form of injectable birth control, administered every three months, which has been on the market since its approval by the FDA in 1992. Known generically as medroxyprogesterone acetate, the drug operates … Read more